Holly Hamilton

机构：University of Minnesota, Royal Brisbane and Women's Hospital, Minneapolis VA Health Care System

发表论文 57 篇 · 总被引 1627 次 · h-index 16

代表论文

• Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease (2020 · JCI Insight · 被引 59)
• HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell Carcinoma (2017 · Molecular Cancer Therapeutics · 被引 31)
• Personalized Medicine for Dyslipidemias by RNA Interference-Mediated Reductions in Apolipoprotein C3 or Angiopoietin-Like Protein 3 (2019 · Journal of clinical lipidology · 被引 9)
• Abstract 17167: Targeting Apolipoprotein(a) With a Novel RNAi Delivery Platform as a Prophylactic Treatment to Reduce Risk of Cardiovascular Events in Individuals With Elevated Lipoprotein (a) (2016 · Circulation · 被引 7)
• Abstract 4775: Optimizing the potency and dosing design for ARO-HIF2: An RNAi therapeutic for clear cell renal cell carcinoma (2019 · Cancer Research · 被引 5)
• E‐Cigarette Education and Training in Medical Schools: A National Survey (2025 · Pediatric Pulmonology · 被引 3)